With HIV rising, UMBI tailors vaccine f...( ABUJA Nigeria-Research parasit...)

With HIV rising, UMBI tailors vaccine for Nigeria

ABUJA, Nigeria-Research parasitologist Simon Agwale at the University of Maryland Biotechnology Institute (UMBI), reported here today that he and colleagues have developed an experimental HIV-1 vaccine, tailored specifically to help fight AIDS in his native Nigeria.

According to the UNAIDS/World Health Organization, HIV infections have risen steeply in Nigeria in the past few years, posing a serious threat to the most populous country in Africa and where high costs make anti-HIV drugs largely unavailable to the general population.

Agwale reported that the research team at UMBI's Institute of Human Virology (IHV) has applied the latest IHV vaccine technology to build a "first generation Nigerian HIV-1 vaccine." The vaccine is made up of bits of the specific subtypes of HIV predominating Nigerian infections. He said the bits of HIV in the vaccine were identified by the first complete nationwide analysis of blood from HIV positive individuals in all 36 states of Nigeria, conducted in collaboration with the Centers for Disease Control and Prevention (CDC) in Atlanta, Ga.

Agwale is currently a post-doctoral fellow the laboratory of David Hone, IHV associate professor. "I am in a position to help my nation with its growing AIDS problem. I have a lot of faith in this approach to developing a vaccine and now we have a plan to put it to use," said Agwale. The experimental Nigerian HIV-1 vaccine is now entering preclinical testing in laboratory animals. IHV has designed the vaccine to be taken orally, thus eliminating the need for maintaining sterile injection needles. Agwale announced the vaccine during a three-day National Workshop on HIV Vaccine Plan for Nigeria, sponsored by UNAIDS/WHO.

The candidate Nigerian HIV-1 vaccine is potentially applicable to all of Africa, said Agwale, because the IHV team has also included a piece of DNA from the C clade variation of HIV-1, which is rapidly becoming the predominant subtype of HIV-1 in many Afr
'"/>

Contact: steve berberich
berberic@umbi.umd.edu
301-738-6295
University of Maryland Biotechnology Institute
15-Jan-2001

Page: 1 2 3
Related biology news :

1. MIT team tailors cell jackets to prevent cancer
2. Cancer vaccine based on pathogenic listeria bacteria shows promise targeting metastases
3. Pneumococcal vaccine reduces ear infections, pneumonia, new study shows
4. UC Irvine scientists to develop vaccine to combat bioterrorism threat from deadly bacteria
5. First clinical study of new pediatric croup vaccine shows safety, tolerability in adults
6. Protective gene may enhance vaccine responses
7. Protein vaccine fully protects mice from lethal aerosol challenge with ricin toxin
8. New glycan arrays discover autoimmunogenic activities of SARS-CoV: concern over monkey vaccine
9. Growing new breed of vaccine-producing plants to fight human diseases worldwide
10. Childrens Hospital Boston receives more than $10 million to help make smallpox vaccine safer
11. Triple-vaccine strategy stimulates strong HIV-specific immune response in monkeys

Post Your Comments:

(Date:5/23/2013)... Public Health at Emory University, along with partners ... a $4 million grant over four years to ... and Exposome Research Center: Understanding Lifetime Exposures). The ... in the United States. , The HERCULES ... Environmental Health Sciences (NIEHS) of the National Institutes ...

(Date:5/23/2013)... wrapping of genomic DNA around nucleosomes in the ... A team of Ludwig-Maximilians-Universitaet (LMU) in Munich now ... be locally displaced from nucleosomes for transcription. , ... in the cell nucleus, wrapped around disk-shaped particles ... four different histone proteins and accommodating two loops ...

(Date:5/23/2013)... unnecessarily undergo surgery or harsh treatments because science ... aggressive forms of the disease. Researchers at Case ... are developing technology that allows patients to safely ... treatments or take drastic measures. , The project ... professor of biomedical engineering at Case Western Reserve ...

Breaking Biology News(10 mins):Emory, Georgia Tech receive first human exposome center grant in US 2 Emory, Georgia Tech receive first human exposome center grant in US 3 Biochemistry: Unspooling DNA from nucleosomal disks 2 Using big data to identify prostate cancers and best treatments 2 Using big data to identify prostate cancers and best treatments 3

[0] Emory, Georgia Tech receive first human exposome center grant in US [0] Biochemistry: Unspooling DNA from nucleosomal disks [0] Using big data to identify prostate cancers and best treatments

(Date:5/24/2013)... Madison, WI (PRWEB) May 24, 2013 ... to the discovery and development of calcium-binding proteins ... publication of safety assessment study of apoaequorin ... an international journal published for the British Industrial ... the study was to investigate potential adverse effects, ...

(Date:5/23/2013)... Can economic incentives such as gift cards, ... the public to increase their donations of blood? , ... Business School Assistant Professor Mario Macis says the ... body of recent research that supports their argument, the ... of Science that the World Health Organization and national ...

(Date:5/23/2013)... 2013 The maker community is a ... inventions. They focus on learning practical skills while applying ... toward bringing their ideas to life via crowdfunding. A ... on making projects using biology. Glowing Plant has worked ... make them glow with bioluminescence genes, and has now ...

(Date:5/23/2013)... 23, 2013 BioTrends Research Group, one ... for specialized biopharmaceutical issues, finds that, unaided, one ... specialists reported that in the past six months, ... treatment) in anticipation of the next generation of ... when only 6 percent reported that they had ...

Breaking Biology Technology:Safety Assessment Study of Apoaequorin Published in Food and Chemical Toxicology 2 Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 2 Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 3 Glowing Plant Releases Maker Kit, Enabling Anyone to Make a Glowing Plant at Home 2 The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 2 The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 3

[0] Safety Assessment Study of Apoaequorin Published in Food and Chemical Toxicology [0] Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science [0] Glowing Plant Releases Maker Kit, Enabling Anyone to Make a Glowing Plant at Home [0] The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments

Cached News:

Stretching DNA on a tiny scale, researchers probe the basis for its compaction Gulf of Maine Ocean Data Partnership announced Clemson dedicates biotech research complex Discovery offers clues to origin of life

15 million cancer research coup New route to Parkinson's found in cells' 'garbage disposal' system Oxidants link obesity to diabetes Loss of fruit fly retina protein delays blinding light damage